Personal information

Emails & domains

Verified email addresses

Activities

Collapse all

Employment (1)

Duke Medicine: Durham, NC, US

2016-01-01 to present | Professor and Chairman (Pathology)
Employment
Source: Self-asserted source
Jiaoti Huang

Education and qualifications (6)

Memorial Sloan Kettering Cancer Center: New York, NY, US

1999-07-01 to 2000-06-30 | Fellow in Oncologic Surgical Pathology (Pathology)
Qualification
Source: Self-asserted source
Jiaoti Huang

NYU Langone Medical Center: NY, NY, US

1995-07-01 to 1999-06-30 | Residency in Anatomic and Clinical Pathology (Pathology)
Qualification
Source: Self-asserted source
Jiaoti Huang

Yale University: New Haven, Connecticut, US

1994-07-01 to 1995-06-30 | Postdoctoral fellow (Medicine)
Qualification
Source: Self-asserted source
Jiaoti Huang

NYU Langone Medical Center: NY, NY, US

1991-01-01 to 1994-06-30 | Posdoctoral fellow (Pharmacology)
Qualification
Source: Self-asserted source
Jiaoti Huang

New York University: New York, NY, US

1987-09-01 to 1990-12-31 | Ph.D. (Biochemistry)
Education
Source: Self-asserted source
Jiaoti Huang

Anhui Medical University: Hefei, Anhui, CN

1978-09-01 to 1983-06-01 | MD
Education
Source: Self-asserted source
Jiaoti Huang

Funding (8)

Targeting Glutaminase Isoforms for Therapy-Resistant Prostate Cancer

2017-10-01 to 2018-09-01 | Grant
Congressionally Directed Medical Research Programs (Frederick, US)
URL: https://app.dimensions.ai/details/grant/grant.8550808
GRANT_NUMBER:

W81XWH-19-1-0411
Source: Self-asserted source
Jiaoti Huang via DimensionsWizard

Role of oncogenic phosphorylated MED1 in aggressive prostate cancer

2017-07-01 to 2022-06-30 | Grant
National Cancer Institute (Rockville, US)
URL: https://app.dimensions.ai/details/grant/grant.6952348
GRANT_NUMBER: R01CA200853
Source: Self-asserted source
Jiaoti Huang via DimensionsWizard

Role and targeting of PRMT5 in prostate cancer

2017-06-09 to 2022-05-31 | Grant
National Cancer Institute (Rockville, US)
URL: https://app.dimensions.ai/details/grant/grant.6918845
GRANT_NUMBER: R01CA212403
Source: Self-asserted source
Jiaoti Huang via DimensionsWizard

Histologic and Immunohistochemical Biomarkers for Heavily Treated Metastatic Prostate Cancer.

2016-07-01 to 2021-06-30 | Grant
National Cancer Institute (Rockville, US)
URL: https://app.dimensions.ai/details/grant/grant.5476649
GRANT_NUMBER: R01CA205001
Source: Self-asserted source
Jiaoti Huang via DimensionsWizard

Novel Tumor Suppressive Role of Phosphodiesterases in Prostate Cancer

2014-10-01 to 2015-09-01 | Grant
Congressionally Directed Medical Research Programs (Frederick, US)
URL: https://app.dimensions.ai/details/grant/grant.7144908
GRANT_NUMBER:

W81XWH-16-1-0292
Source: Self-asserted source
Jiaoti Huang via DimensionsWizard

A novel strategy to identify prostate cancer biomarkers for patient management

2013-07-01 to 2018-05-31 | Grant
National Cancer Institute (Rockville, US)
URL: https://app.dimensions.ai/details/grant/grant.2482215
GRANT_NUMBER: R01CA172603
Source: Self-asserted source
Jiaoti Huang via DimensionsWizard

The Function of Neuroendocrine Cells in Prostate Cancer

2009-10-01 to 2010-09-01 | Grant
Congressionally Directed Medical Research Programs (Frederick, US)
URL: https://app.dimensions.ai/details/grant/grant.7144216
GRANT_NUMBER:

W81XWH-11-1-0227
Source: Self-asserted source
Jiaoti Huang via DimensionsWizard

The Function of PTP1B in Neuroendocrine Differentiation of Prostate Cancer

2005-10-01 to 2006-09-01 | Grant
Congressionally Directed Medical Research Programs (Frederick, US)
URL: https://app.dimensions.ai/details/grant/grant.7143666
GRANT_NUMBER:

W81XWH-07-1-0061
Source: Self-asserted source
Jiaoti Huang via DimensionsWizard
How many people are using ORCID?